References
- Chalabianloo F. Hypersensitivity reactions to nonsteroidal anti-inflammatory drugs. Tidsskriftet. 2012;132(17):1961–1963.
- Kowalski ML, Makowska JS, Blanca M, et al. Hypersensitivity to nonsteroidal anti‐inflammatory drugs (NSAIDs)–classification, diagnosis and management: review of the EAACI/ENDA# and GA2LEN/HANNA*. Allergy. 2011;66:818–829.
- Curry SL, Cogar SM, Cook JL. Nonsteroidal anti-inflammatory drugs: a review. J Am Anim Hosp Assoc. 2005;41(5):298–309.
- Rençber S, Karavana SY, Ozyazici M. Bioavailability file: ketoprofen. FABAD J Pharm Sci. 2009;34:203–216.
- Matthieu L, Meuleman L, Van Hecke E, et al. Contact and photocontact allergy to ketoprofen. The Belgian experience. Contact Dermatitis. 2004;50(4):238–241.
- Cantisani C, Grieco T, Faina V, et al. Ketoprofen allergic reactions. Recent Pat Inflamm Allergy Drug Discov. 2010;4(1):58–64.
- Rindo T, Oiso N, Yamadori Y, et al. Photoallergic contact dermatitis due to ketoprofen and hydrogenated rosin glycerol ester. Case Rep Dermatol. 2010;2(1):36–39.
- Milpied-Homsi B. Allergies to ketoprofen gels. Presse Med. 2001;30(12):605–609.
- Mota I, Gaspar A, Morais-Almeida M. Hypersensitivity to nonsteroidal anti-inflammatory drugs: from pathogenesis to clinical practice. Rev Port Imunoalergologia. 2018;26:207–220.
- Sanchez-Borges M, Capriles-Hulett A. A novel phenotype of nonsteroidal anti-inflammatory drug hypersensitivity the high-risk patient. World Allergy Organ J. 2009;2:17.
- Ayuso P, Blanca-López N, Doña I, et al. Advanced phenotyping in hypersensitivity drug reactions to NSAIDs. Clin Exp Allergy. 2013;43:1097–1109.
- Asero R, Bavbek S, Blanca M, et al. Clinical management of patients with a history of urticaria/angioedema induced by multiple NSAIDs: an expert panel review. Int Arch Allergy Immunol. 2013;160(2):126–133.
- Sánchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A, et al. Hypersensitivity reactions to nonsteroidal anti-inflammatory drugs: an update. Pharmaceuticals. 2010;3(1):10–18.
- Demir S, Olgac M, Unal D, et al. Evaluation of hypersensitivity reactions to nonsteroidal anti-inflammatory drugs according to the latest classification. Allergy. 2015;70(11):1461–1467.
- Cavkaytar O, Arik Yilmaz E, Karaatmaca B, et al. Different phenotypes of non-steroidal anti-inflammatory drug hypersensitivity during childhood. Int Arch Allergy Immunol. 2015;167(3):211–221.
- Quiralte J, Blanco C, Castillo R, et al. Intolerance to nonsteroidal antiinflammatory drugs: results of controlled drug challenges in 98 patients. J Allergy Clin Immunol. 1996;98(3):678–685.
- Sánchez-Borges M, Acevedo N, Vergara C, et al. The A-444C polymorphism in the leukotriene C4 synthase gene is associated with aspirin-induced urticaria. J Investig Allergol Clin Immunol. 2009;19(5):375–382.
- Nettis E, Giordano D, Colanardi MC, et al. Delayed‐type hypersensitivity rash from ibuprofen. Allergy. 2003;58(6):539–540.
- Kowalski ML, Asero R, Bavbek S, et al. Classification and practical approach tothe diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy. 2013;68(10):1219–1232.
- Picado C. The role of cyclooxygenase in acetylsalicylic acid sensitivity. Allergy Clin Immunol Int J World Allergy Org. 2006;18(04):154–157.
- Doña I, Pérez‐Sánchez N, Eguiluz-Gracia I, et al. Progress in understanding hypersensitivity reactions to nonsteroidal anti‐inflammatory drugs. Allergy. 2019;1–15. DOI:10.1111/all.14032
- Agúndez JA, Ayuso P, Cornejo-García JA, et al. The diamine oxidase gene is associated with hypersensitivity response to non-steroidal anti-inflammatory drugs. PloS One. 2012;7(11):e47571.
- Sánchez-Borges M. Clinical management of nonsteroidal anti-inflammatory drug hypersensitivity. World Allergy Organ J. 2008;1(2):29–33.
- Mita H, Endoh S, Kudoh M, et al. Possible involvement of mast-cell activation in aspirin provocation of aspirin-induced asthma. Allergy. 2008;56(11):1061–1067.
- Amo G, Martí M, García-Menaya JM, et al. Identification of novel biomarkers for drug hypersensitivity after sequencing of the promoter area in 16 genes of the vitamin D pathway and the high-affinity IgE receptor. Front Genet. 2019;10:582.
- Woessner KM, Castells M. NSAID single-drug-induced reactions. Immunol Allergy Clin North Am. 2013;33(2):237–249.
- Abuaf N, Rostane H, Barbara J, et al. Comparison of CD63 upregulation induced by NSAIDs on basophils and monocytes in patients with NSAID hypersensitivity. J Allergy. 2012;2012:580873.
- Bonaventure C, Nancey S, Pont E, et al. Ketoprofen-induced acute hepatitis. Gastroenterol Clin Biol. 2001;25(6–7):716–717.
- Nores JM, Rambaud S, Remy JM. Acute hepatitis due to ketoprofen. Clin Rheumatol. 1991;10(2):215–216.
- Boelsterli UA, Zimmerman HJ, Kretz-Rommel A. Idiosyncratic liver toxicity of nonsteroidal antiinflammatory drugs: molecular mechanisms and pathology. Crit Rev Toxicol. 1995;25(3):207–235.
- Rodriguez LAG, Gutthann SP, Walker AM, et al. The role of non-steroidal anti-inflammatory drugs in acute liver injury. BMJ. 1992;305(6858):865–868.
- O'Connor N, Dargan PI, Jones AL. Hepatocellular damage from non-steroidal anti-inflammatory drugs. QJM. 2003;96(11):787–791.
- Famularo G, Gasbarrone L, Minisola G. Probable ketoprofen associated nonalcoholic fatty liver disease and steatohepatitis. Ann Pharmacother. 2011;45(3):423–423.
- Lu W, Cheng F, Jiang J, et al. FXR antagonism of NSAIDs contributes to drug-induced liver injury identified by systems pharmacology approach. Sci Rep. 2015;5(1):8114.
- Vítek L, Ostrow JD. Bilirubin chemistry and metabolism; harmful and protective aspects. Curr Pharm Des. 2009;15(25):2869–2883.
- Joseph A, Jaundice SH. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 [Updated 2019 Jul 7]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK544252.
- Reisdorph N, Wechsler ME. Utilizing metabolomics to distinguish asthma phenotypes: strategies and clinical implications. Allergy. 2013;68(8):959–962.